These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
796 related items for PubMed ID: 19671032
1. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K. Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032 [Abstract] [Full Text] [Related]
3. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620 [Abstract] [Full Text] [Related]
4. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Gutta R, Louis PJ. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug 01; 104(2):186-93. PubMed ID: 17448709 [Abstract] [Full Text] [Related]
5. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Marx RE, Sawatari Y, Fortin M, Broumand V. J Oral Maxillofac Surg; 2005 Nov 01; 63(11):1567-75. PubMed ID: 16243172 [Abstract] [Full Text] [Related]
6. Bisphosphonates and osteonecrosis of the jaws. Mariotti A. J Dent Educ; 2008 Aug 01; 72(8):919-29. PubMed ID: 18676801 [Abstract] [Full Text] [Related]
7. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P. Breast; 2009 Aug 01; 18(4):213-7. PubMed ID: 19651512 [Abstract] [Full Text] [Related]
8. Complication related to bisphosphonate therapy: osteonecrosis of the jaw. Lee J. J Infus Nurs; 2009 Aug 01; 32(6):330-5. PubMed ID: 19918142 [Abstract] [Full Text] [Related]
9. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma. Migliorati CA, Hsu CJ, Chopra S, Kaltman SS. J Calif Dent Assoc; 2008 Oct 01; 36(10):769-74. PubMed ID: 19044097 [Abstract] [Full Text] [Related]
10. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases]. Gering A, Grange L, Villier C, Woeller A, Mallaret M. Therapie; 2007 Oct 01; 62(1):49-54. PubMed ID: 17374348 [Abstract] [Full Text] [Related]
11. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Grewal VS, Fayans EP. Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452 [Abstract] [Full Text] [Related]
13. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports]. Schortinghuis J, Meijndert L, de Visscher JG, Witjes MJ. Ned Tijdschr Tandheelkd; 2007 Oct 01; 114(10):432-5. PubMed ID: 17972612 [Abstract] [Full Text] [Related]
15. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw. Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association. Hawaii Dent J; 2008 Oct 01; 39(5):9-12; quiz 17. PubMed ID: 19189512 [Abstract] [Full Text] [Related]
16. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Ann N Y Acad Sci; 2011 Feb 01; 1218():47-54. PubMed ID: 20946574 [Abstract] [Full Text] [Related]
18. [Bisphosphonates and osteonecrosis of the jaws]. Urade M. Clin Calcium; 2007 Feb 01; 17(2):241-8. PubMed ID: 17272882 [Abstract] [Full Text] [Related]